Clinical Profile and Management of Patients with Newly Diagnosed Type 2 Diabetes Mellitus in Hospital Setting

被引:0
作者
Moreno, Diego Munoz [1 ,2 ]
Lopez, Gilberto Perez [1 ]
Walther, Luis Antonio Alvarez-Sala [3 ]
Camino, Jose Antonio Rueda [4 ]
Vallejo, Javier Martin [5 ]
Albarran, Olga Gonzalez [1 ]
机构
[1] Gen Univ Gregorio Maranon Hosp, Endocrinol & Nutr Dept, C Dr Esquerdo 46, Madrid 28007, Spain
[2] Univ Europea Madrid, Madrid, Spain
[3] Gen Univ Gregorio Maranon Hosp, Internal Med Dept, Madrid, Spain
[4] Rey Juan Carlos Univ Hosp, Internal Med Dept, Madrid, Spain
[5] Salamanca Biomed Res Inst IBSAL, Dept Biostat Unit, Salamanca, Spain
关键词
Type 2 diabetes mellitus; new-onset; hospitalization; metabolic control; combination therapy; CARDIOVASCULAR RISK-FACTORS; GLYCEMIC CONTROL; PRIMARY-CARE; EUROPE;
D O I
10.1177/11795514251323831
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: New-onset type 2 diabetes mellitus (T2DM) is a common clinical scenario in the hospital settings. However, data on the baseline characteristics of these patients at diagnosis in Spain remain limited.Objectives: This study aims to describe the characteristics of 165 patients admitted to a Spanish tertiary hospital with new-onset T2DM. We analysed the use of different treatment regimens at discharge and metabolic control during follow-up.Methods: A retrospective, single-centre cohort study was conducted at General University Gregorio Mara & ntilde;& oacute;n Hospital, between January 2018 and April 2021.Results: A total of 165 patients participated, with a mean age of 56.4 years, 62.4% of whom were men. Diabetes-related complications were observed in 24.8% of patients at diagnosis. Combined antidiabetic treatment was required in 87% of cases. The mean baseline HbA1c was 10.8%, which decreased by 4.9% after 8 months of follow-up.Conclusion: The clinical heterogeneity and severity of hyperglycaemia in this cohort presented management challenges, in contrast to outpatient settings. Monotherapy was rarely used, with higher adoption of SGLT-2 inhibitors and GLP-1 receptor agonists compared to other studies. Additional research is needed to refine treatment strategies and optimize care for patients with newly diagnosed T2DM.
引用
收藏
页数:8
相关论文
共 27 条
[1]   Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91) [J].
Adler, Amanda, I ;
Coleman, Ruth L. ;
Leal, Jose ;
Whiteley, William N. ;
Clarke, Philip ;
Holman, Rury R. .
LANCET, 2024, 404 (10448) :145-155
[2]   Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER [J].
Arnold, Suzanne V. ;
Tang, Fengming ;
Cooper, Andrew ;
Chen, Hungta ;
Gomes, Marilia B. ;
Rathmann, Wolfgang ;
Shimomura, Iichiro ;
Vora, Jiten ;
Watada, Hirotaka ;
Khunti, Kamlesh ;
Kosiborod, Mikhail .
BMC ENDOCRINE DISORDERS, 2022, 22 (01)
[3]   Early determinants of type-2 diabetes [J].
Berends, L. M. ;
Ozanne, S. E. .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 26 (05) :569-580
[4]   Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetes [J].
Boehm, Anna-Katharina ;
Schneider, Udo ;
Aberle, Jens ;
Stargardt, Tom .
PLOS ONE, 2021, 16 (05)
[5]   Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 [J].
Bonora, Enzo ;
Trombetta, Maddalena ;
Dauriz, Marco ;
Travia, Daniela ;
Cacciatori, Vittorio ;
Brangani, Corinna ;
Negri, Carlo ;
Perrone, Fabrizia ;
Pichiri, Isabella ;
Stoico, Vincenzo ;
Zoppini, Giacomo ;
Rinaldi, Elisabetta ;
Da Prato, Giuliana ;
Boselli, Maria Linda ;
Santi, Lorenza ;
Moschetta, Federica ;
Zardini, Monica ;
Bonadonna, Riccardo C. .
BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
[6]   Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications [J].
Brannick, Ben ;
Wynn, Anne ;
Dagogo-Jack, Samuel .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 241 (12) :1323-1331
[7]  
Carreo Hernndez MC., 2005, An Med Interna Madrid, V22, P339
[8]   Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study [J].
de Pablos-Velasco, Pedro ;
Parhofer, Klaus G. ;
Bradley, Clare ;
Eschwege, Eveline ;
Goender-Frederick, Linda ;
Maheux, Pierre ;
Wood, Ian ;
Simon, Dominique .
CLINICAL ENDOCRINOLOGY, 2014, 80 (01) :47-56
[9]   Phenotypic and genetic classification of diabetes [J].
Deutsch, Aaron J. ;
Ahlqvist, Emma ;
Udler, Miriam S. .
DIABETOLOGIA, 2022, 65 (11) :1758-1769
[10]   Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024 [J].
ElSayed, Nuha A. ;
Aleppo, Grazia ;
Bannuru, Raveendhara R. ;
Bruemmer, Dennis ;
Collins, Billy S. ;
Ekhlaspour, Laya ;
Gaglia, Jason L. ;
Hilliard, Marisa E. ;
Johnson, Eric L. ;
Khunti, Kamlesh ;
Lingvay, Ildiko ;
Matfin, Glenn ;
McCoy, Rozalina G. ;
Perry, Mary Lou ;
Pilla, Scott J. ;
Polsky, Sarit ;
Prahalad, Priya ;
Pratley, Richard E. ;
Segal, Alissa R. ;
Seley, Jane Jeffrie ;
Stanton, Robert C. ;
Gabbay, Robert A. ;
Beverly, Elizabeth A. ;
Cusi, Kenneth ;
Darville, Audrey ;
Das, Sandeep R. ;
Fleming, Talya K. ;
Gaglia, Jason L. ;
Galindo, Rodolfo J. ;
Gibbons, Christopher H. ;
Giurini, John M. ;
Hassanein, Mohamed ;
Kosiborod, Mikhail N. ;
Kushner, Robert F. ;
Murdock, Lisa ;
Napoli, Nicola ;
Selvin, Elizabeth ;
Silva, Paolo S. ;
Verduzco-Gutierrez, Monica ;
Woodward, Crystal C. ;
Younossi, Zobair M. ;
Pekas, Elizabeth J. ;
Yacoubian, Alexandra M. .
DIABETES CARE, 2024, 47 :S158-S178